** Carbon recycling firm LanzaTech Global's LNZA.O shares rise 5.3% to $1.58 premarket
** On Tuesday, LNZA said it is spinning out its synthetic biology platform, LanzaX, into a joint venture with Tharsis Capital to accelerate project development and financing
** The spin-out of LanzaX is expected to reduce LNZA's cost structure by ~$8 mln annually, company said
** LNZA said it's contributing its existing synbio contracts, 100+ developed molecules, and commercial expertise to LanzaX to accelerate product development
** LNZA said it is appointing a new interim chief financial officer, Justin Pugh, to focus on cost reductions and resource reallocation for its biorefining business
** LNZA fell ~71% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.